Home/Filings/4/0001104659-20-027400
4//SEC Filing

Lampropoulos Justin J. 4

Accession 0001104659-20-027400

CIK 0000856982other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 9:38 PM ET

Size

16.9 KB

Accession

0001104659-20-027400

Insider Transaction Report

Form 4
Period: 2020-02-26
Lampropoulos Justin J.
EXEC. V.P. MKTG & STRATEGY
Transactions
  • Award

    Non-qualified stock options (right to buy)

    2020-02-26+16,72216,722 total
    Exercise: $37.71From: 2021-02-26Exp: 2027-02-26Common Stock (16,722 underlying)
  • Award

    Performance Share Units

    2020-02-26+7,9557,955 total
    From: 2021-03-15Exp: 2023-03-15Common Stock (7,955 underlying)
Holdings
  • Non-qualified stock options (right to buy)

    Exercise: $12.06From: 2015-10-04Exp: 2021-10-04Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $17.27From: 2016-02-13Exp: 2022-02-13Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $16.05From: 2017-01-28Exp: 2023-01-28Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $28.20From: 2018-04-14Exp: 2024-04-14Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $44.80From: 2019-03-02Exp: 2025-03-02Common Stock (20,000 underlying)
    20,000
  • Non-qualified stock options (right to buy)

    Exercise: $55.73From: 2020-03-01Exp: 2026-03-01Common Stock (30,000 underlying)
    30,000
Footnotes (10)
  • [F1]Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
  • [F10]If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement.
  • [F2]Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
  • [F3]Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
  • [F4]Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
  • [F5]Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
  • [F6]Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020..
  • [F7]Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
  • [F8]Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria.
  • [F9]On February 26, 2020, the reporting person was awarded a target number of performance share units ("PSUs") pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement.

Documents

1 file

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001643609

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 9:38 PM ET
Size
16.9 KB